ProMIS Neurosciences, Inc. (PMN)
NASDAQ·Healthcare·Biotechnology
$11.00
-0.90%
Mkt Cap $31.08M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 25, 2026 | — | — | — | -$4.66 | -$4.11 | +11.80% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$3.75 | -$6.00 | -60.00% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.22 | -$0.29 | -31.82% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$0.12 | -$0.21 | -75.00% | — | — |
| Q1 2025 Mar 31, 2025 | — | — | — | -$0.14 | -$0.02 | +85.71% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$0.07 | -$0.14 | -100.00% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.14 | -$0.13 | +7.14% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.20 | -$0.19 | +5.00% | — | — |
| Q2 2024 Apr 1, 2024 | — | $4.72K | — | -$0.17 | -$0.09 | +47.06% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.33 | -$0.19 | +42.42% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | — | -$0.27 | — | — | — |
| Q2 2023 May 15, 2023 | — | — | — | — | -$0.58 | — | — | — |
| Q1 2023 Mar 8, 2023 | — | -$3.11K | — | — | -$0.90 | — | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | — | -$0.85 | — | — | — |
| Q3 2022 Aug 12, 2022 | — | — | — | — | -$0.38 | — | — | — |
| Q2 2022 May 13, 2022 | — | $2.67K | — | — | -$0.60 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | $3.25K | — | — | -$0.30 | — | — | — |
| Q4 2021 Nov 12, 2021 | — | $3.15K | — | — | -$0.16 | — | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | — | -$0.04 | — | — | — |
| Q2 2021 May 14, 2021 | — | — | — | -$0.45 | -$0.98 | -114.93% | — | — |